[5-amino-1-(2-methyl-3H-benzimidazol-5-yl)pyrazol-4-yl]-(3,4-dipyridin-3-ylcyclopenta-1,3-dien-1-yl)methanone
C27H21N7O — CID 158875544
Data last refreshed: (MolForge compound catalog, from PubChem)
About [5-amino-1-(2-methyl-3H-benzimidazol-5-yl)pyrazol-4-yl]-(3,4-dipyridin-3-ylcyclopenta-1,3-dien-1-yl)methanone
[5-amino-1-(2-methyl-3H-benzimidazol-5-yl)pyrazol-4-yl]-(3,4-dipyridin-3-ylcyclopenta-1,3-dien-1-yl)methanone (PubChem CID 158875544) has the molecular formula C27H21N7O and a molecular weight of 459.51 g/mol. Its IUPAC name is [5-amino-1-(2-methyl-3H-benzimidazol-5-yl)pyrazol-4-yl]-(3,4-dipyridin-3-ylcyclopenta-1,3-dien-1-yl)methanone.
Molecular Properties
| Compound Name | [5-amino-1-(2-methyl-3H-benzimidazol-5-yl)pyrazol-4-yl]-(3,4-dipyridin-3-ylcyclopenta-1,3-dien-1-yl)methanone |
|---|---|
| PubChem CID | 158875544 |
| Molecular Formula | C27H21N7O |
| Molecular Weight | 459.51 g/mol |
| Exact Mass | 459.18 |
| IUPAC Name | [5-amino-1-(2-methyl-3H-benzimidazol-5-yl)pyrazol-4-yl]-(3,4-dipyridin-3-ylcyclopenta-1,3-dien-1-yl)methanone |
| SMILES | Cc1nc2ccc(-n3ncc(C(=O)C4=CC(c5cccnc5)=C(c5cccnc5)C4)c3N)cc2[nH]1 |
| InChI | InChI=1S/C27H21N7O/c1-16-32-24-7-6-20(12-25(24)33-16)34-27(28)23(15-31-34)26(35)19-10-21(17-4-2-8-29-13-17)22(11-19)18-5-3-9-30-14-18/h2-10,12-15H,11,28H2,1H3,(H,32,33) |
| InChIKey | JCJPRDPZZOWEGS-UHFFFAOYSA-N |
| XLogP | 4.55 |
| TPSA | 115.37 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 7 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 35 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 459.51 |
| LogP ≤ 5 | 4.55 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 7 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158875544 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.